KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Bausch Health Companies (BHC) over the last 15 years, with Q3 2025 value amounting to $371.3 million.

  • Bausch Health Companies' Shares Outstanding (Weighted Average) rose 78.72% to $371.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $371.3 million, marking a year-over-year increase of 78.72%. This contributed to the annual value of $368.0 million for FY2024, which is 84.95% up from last year.
  • Per Bausch Health Companies' latest filing, its Shares Outstanding (Weighted Average) stood at $371.3 million for Q3 2025, which was up 78.72% from $370.9 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Shares Outstanding (Weighted Average) ranged from a high of $371.3 million in Q3 2025 and a low of $356.8 million during Q1 2021
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $364.8 million (2023), whereas its average is $364.4 million.
  • In the last 5 years, Bausch Health Companies' Shares Outstanding (Weighted Average) soared by 112.49% in 2021 and then soared by 69.29% in 2023.
  • Bausch Health Companies' Shares Outstanding (Weighted Average) (Quarter) stood at $358.9 million in 2021, then increased by 0.86% to $362.0 million in 2022, then increased by 0.8% to $364.9 million in 2023, then increased by 0.85% to $368.0 million in 2024, then increased by 0.9% to $371.3 million in 2025.
  • Its last three reported values are $371.3 million in Q3 2025, $370.9 million for Q2 2025, and $369.6 million during Q1 2025.